Greil R - Search Results

1

ASCO 2018 highlights: metastatic breast cancer.

Rinnerthaler G, Gampenrieder SP, Greil R. Rinnerthaler G, et al. Among authors: greil r. Memo. 2018;11(4):276-279. doi: 10.1007/s12254-018-0450-9. Epub 2018 Nov 20. Memo. 2018. PMID: 30595753 Free PMC article. Review.

2

Neoadjuvant chemotherapy and targeted therapy in breast cancer: past, present, and future.

Gampenrieder SP, Rinnerthaler G, Greil R. Gampenrieder SP, et al. Among authors: greil r. J Oncol. 2013;2013:732047. doi: 10.1155/2013/732047. Epub 2013 Aug 20. J Oncol. 2013. PMID: 24027583 Free PMC article. Review.

3

Overcoming resistance against HER2-targeting agents in fifth-line therapy: is there still a place for bevacizumab in HER2+ breast cancer?

Huemer F, Gampenrieder SP, Schlattau A, Greil R. Huemer F, et al. Among authors: greil r. Clin Breast Cancer. 2014 Feb;14(1):e17-20. doi: 10.1016/j.clbc.2013.09.009. Epub 2013 Sep 28. Clin Breast Cancer. 2014. PMID: 24246725 No abstract available.

4

Female gender may predict response to FOLFIRINOX in patients with unresectable pancreatic cancer: a single institution retrospective review.

Hohla F, Hopfinger G, Romeder F, Rinnerthaler G, Bezan A, Stättner S, Hauser-Kronberger C, Ulmer H, Greil R. Hohla F, et al. Among authors: greil r. Int J Oncol. 2014 Jan;44(1):319-26. doi: 10.3892/ijo.2013.2176. Epub 2013 Nov 15. Int J Oncol. 2014. PMID: 24247204

5

Hypertension as a predictive marker for bevacizumab in metastatic breast cancer: results from a retrospective matched-pair analysis.

Gampenrieder SP, Romeder F, Muß C, Pircher M, Ressler S, Rinnerthaler G, Bartsch R, Sattlberger C, Mlineritsch B, Greil R. Gampenrieder SP, et al. Among authors: greil r. Anticancer Res. 2014 Jan;34(1):227-33. Anticancer Res. 2014. PMID: 24403467 Clinical Trial.

6

Lapatinib-plus-pegylated liposomal doxorubicin in advanced HER2-positive breast cancer following trastuzumab: a phase II trial.

Pircher M, Mlineritsch B, Fridrik MA, Dittrich C, Lang A, Petru E, Weltermann A, Thaler J, Hufnagl C, Gampenrieder SP, Rinnerthaler G, Ressler S, Ulmer H, Greil R. Pircher M, et al. Among authors: greil r. Anticancer Res. 2015 Jan;35(1):517-21. Anticancer Res. 2015. PMID: 25550597 Clinical Trial.

7

Bone-targeted therapy in metastatic breast cancer - all well-established knowledge?

Gampenrieder SP, Rinnerthaler G, Greil R. Gampenrieder SP, et al. Among authors: greil r. Breast Care (Basel). 2014 Oct;9(5):323-30. doi: 10.1159/000368710. Breast Care (Basel). 2014. PMID: 25759612 Free PMC article. Review.

8

miR-16-5p Is a Stably-Expressed Housekeeping MicroRNA in Breast Cancer Tissues from Primary Tumors and from Metastatic Sites.

Rinnerthaler G, Hackl H, Gampenrieder SP, Hamacher F, Hufnagl C, Hauser-Kronberger C, Zehentmayr F, Fastner G, Sedlmayer F, Mlineritsch B, Greil R. Rinnerthaler G, et al. Among authors: greil r. Int J Mol Sci. 2016 Jan 26;17(2):156. doi: 10.3390/ijms17020156. Int J Mol Sci. 2016. PMID: 26821018 Free PMC article.

9

Clonal evolution in relapsed and refractory diffuse large B-cell lymphoma is characterized by high dynamics of subclones.

Melchardt T, Hufnagl C, Weinstock DM, Kopp N, Neureiter D, Tränkenschuh W, Hackl H, Weiss L, Rinnerthaler G, Hartmann TN, Greil R, Weigert O, Egle A. Melchardt T, et al. Among authors: greil r. Oncotarget. 2016 Aug 9;7(32):51494-51502. doi: 10.18632/oncotarget.9860. Oncotarget. 2016. PMID: 27285986 Free PMC article.

10

CDK4/6 inhibition in luminal breast cancer.

Gampenrieder SP, Rinnerthaler G, Greil R. Gampenrieder SP, et al. Among authors: greil r. Memo. 2016;9:76-81. doi: 10.1007/s12254-016-0268-2. Epub 2016 Jun 20. Memo. 2016. PMID: 27429659 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

665 results

Search Page